Status:
UNKNOWN
Low Level Laser Therapy Plus Topical Clonazepam Treatment to Burning Mouth Symdrome
Lead Sponsor:
Universidad Nacional Autonoma de Mexico
Conditions:
Burning Mouth Syndrome
Eligibility:
All Genders
18-99 years
Phase:
PHASE4
Brief Summary
Burning mouth syndrome (BMS) is a condition that affects the oral mucosa; this is seen mainly in postmenopausal women. The intensity of burning and its clinical manifestations may be variable between ...
Detailed Description
The study will be carried out at the oral medicine clinic of the Division of Postgraduate Studies and Research of the Faculty of Dentistry of the National Autonomous University of Mexico, during the p...
Eligibility Criteria
Inclusion
- Burning mouth sensation without oral lesions that could be involved with painful symptoms
- Symtoms of burning sensation more than 3 months
Exclusion
- Patients who are under antineoplastic treatment or with a history of malignant neoplasms of the head and neck
- Active treatment with benzodiazepines or systemic antidepressants
- Pregnant women
- Patients unable to follow the indications for administration of oral topical medications
- Unstimulated saliva production ≤ 0,1 mililiters/minute
- Sistemic diseases that can produce burning sensation
Key Trial Info
Start Date :
August 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 16 2020
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04313907
Start Date
August 16 2019
End Date
October 16 2020
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division de Estudios de Posgrado e Investigacion en Odontologia, Universidad Nacional Autonoma de Mexico
Mexico City, Mexico, 04360